About Neuralized-like protein 2
Neuralized-like protein 2 (NEURL2) is a protein
from Homo sapiens identified by UniProt accession
Q9BR09, 285 residues long.
MolForge cross-references it against 0 known binders and
46 disease associations.
Target properties
| Protein name | Neuralized-like protein 2 |
| UniProt accession | Q9BR09 |
| Gene | NEURL2 |
| Organism | Homo sapiens |
| Length | 285 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (46)
Diseases linked to this target (Open Targets).
- free cholesterol to total lipids in large HDL percentage · score 0.32
- concentration of large HDL particles measurement · score 0.31
- free cholesterol in very large HDL measurement · score 0.31
- cholesteryl ester measurement · score 0.29
- cholesterol to total lipids in large HDL percentage · score 0.28
- total lipids in very large HDL measurement · score 0.27
- cholesterol in very large HDL measurement · score 0.27
- phospholipids in very large HDL measurement · score 0.27
- high density lipoprotein particle size measurement · score 0.19
- phospholipids:total lipids ratio · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BR09-F1 | alphafold | PREDICTED | 83.03 | — |
Amino-acid sequence (285 residues)
MAAASEPVDS GALWGLERPE PPPTRFHRVH GANIRVDPSG TRATRVESFA HGVCFSREPL APGQVFLVEI EEKELGWCGH LRLGLTALDP ASLAPVPEFS LPDLVNLGHT WVFAITRHHN RVPREGRPEA EAAAPSRPPT LLVEPYLRIE QFRIPRDRLV GRSRPGLYSH LLDQLYELNV LPPTARRSRL GVLFCPRPDG TADMHIIING EDMGPSARGL PAAQPLYAVV DVFASTKSVR LVQLEYGLPS LQTLCRLVIQ RSMVHRLAID GLHLPKELKD FCKYE
Explore Neuralized-like protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets